Michael Wooten, the Alaska State Trooper at the center of the Troopergate scandal in a power struggle of his own – a custody dispute with an ex-wife.

mudflats1

His 12-year-old son did not return to his mother’s home in Washington state as planned at the end of the Thanksgiving holiday weekend, and Wooten’s ex-wife is threatening legal action.

Allocco said if she can’t get the court to issue an emergency order for the return of her son, she will ask the FBI to investigate this as a kidnapping.

“Michael Wooten thinks he is above the law,” Allocco said Monday, after arriving at her lawyer’s office in Anchorage. “What I can’t fathom is why this man is allowed to get away with so much.”

“In my opinion, he has basically kidnapped my child,” she said.
Source: Juneau Empire

We all know that the democrats dug up this mess with this trooper just to try and dirty Gov. Sarah Palin which she was cleared of any wrong doings! But looks like this trooper is still causing himself problems!

LINKS:

(1)  Where’s Sarah? The Return of a Classic.
Palin will stump for Chambliss, the draft-evading incumbent Republican who waged a notoriously misleading campaign against a decorated war hero, at rallies Monday in Atlanta, Augusta, Savannah and Perry, Georgia.

Its like this little mudflats, there are how many democrats in Georgia stumping for the democrat? Did you think to ask muddyflats?

UPDATED DEC 3 – Nuclear, biological attack ‘likely’: US commission – 15,000 Troops Aren’t Enough

bama0803

Nuclear, biological attack ‘likely’: US commission
Terrorists are “likely” to use nuclear or biological weapons in the next five years, a US commission warned Tuesday, highlighting Pakistan as the weakest link in world security.

Without urgent action, “it is more likely than not that a weapon of mass destruction will be used in a terrorist attack somewhere in the world by the end of 2013,” the bi-partisan commission said in its report “World at Risk.”

The report, ordered by Congress and based on six months of research, warned the incoming administration of Barack Obama: “America’s margin of safety is shrinking.”
“There is a grave danger it could also be an unwitting source of a terrorist attack on the United States, possibly with weapons of mass destruction,” the report said.

Congresswoman Jane Harman, the Democrat heading the Homeland Security Subcommittee on Intelligence and Terrorism Risk Assessment, also downplayed the warnings.

It’s time to retire the fear card,” she said in a statement.

SOURCE: AFP

The Congresswoman Jane Harman, the Democrat heading the Homeland Security Subcommittee does not assure me that we can feel safe under Obama as president! I don’t think this was meant to be played as a fear card as she said. We better not let our guard down for one minute! I would feel safe with someone other than Barack Obama which does not have any experience what-so-ever in running a State must less a Country!

UPDATE LINKS:
(1) With WMD Attack Likely, Can the U.S. Cope?
National Security Experts Say 15,000 Troops Aren’t Enough

UPDATED DEC 05 – Asthma inhalers go “green” on Dec. 31, forcing patients still using the old-fashioned kind to make a pricey and even confusing switch.

UPDATE: Dec 05, 2008
If you think taking aerosol out of inhalers is bad then read this!
A Food and Drug Administration analysis of four drugs used to treat asthma said the products are linked with an increased risk of asthma-related side effects, with higher risks seen in children.

The analysis, released Friday, looked at GlaxoSmithKline PLC’s Serevent and Advair, Novartis AG’s and Schering-Plough Corp.’s Foradil and AstraZeneca PLC’s Symbicort.

It looked at whether the drugs increased a combined measure of asthma-related death, hospitalization and asthma-related intubation, or the placement of a tube in patients’ noses or mouths to help them breathe.

The analysis was prepared for an advisory committee meeting next week to discuss the safety of the drugs as a class. The panel will be asked to vote on whether the drugs should continue to be marketed for children and adults.

Agency memos released along with the analysis show the agency is divided over what course of action to take. The FDA’s drug safety division is recommending that the drugs not be marketed for children, and in some cases adults, while the agency’s pulmonary division stated that removing the products from the market would be “extreme.”
SOURCE: The WSJ

Asthma inhalers go “green” on Dec. 31, forcing patients still using the old-fashioned kind to make a pricey and even confusing switch.

The medicine inside these rescue inhalers the albuterol that quickly opens airways during an asthma attack isn’t changing. But the chemicals used to puff that drug into your lungs are.

No more chlorofluorocarbons, or CFCs, which damage Earth’s protective ozone layer. By year’s end, all albuterol inhalers must be powered by the more eco-friendly chemical HFA, or hydrofluoroalkane.

The down side: The new inhalers cost more, $30 to $60 compared with as little as $5 for the disappearing generic CFC inhalers.

And patients face a learning curve. HFA inhalers must be used differently than the old-fashioned kind. The medicine feels and tastes different, sometimes alarming new users despite doctors’ assurances that it works just as well.

Read more here at the source:
SOURCE:  Star-Telegram

Seem that the people pushing green care more about their cause than the people that are sick! Which should come first the sick people or something that the government is not even sure about?

LINKS:
(1) Ozone-Depleting Inhalers Being Phased Out
(2) Respiratory Leaders Urge Medical Community to Educate Patients Transitioning CFC to HFA Inhalers
(3) Deadlines for other inhalers to go eco-friendly
Other types of CFC-containing inhalers will be phased out later.
The Food and Drug Administration has proposed December 2009 as the deadline for seven prescription-only inhalers to either go CFC-free or quit selling. They include:
_Cromolyn and nedocromil, a separate family of drugs used to prevent wheezing, often in connection with allergy exposure.
_Combivent, a combination of albuterol and ipratropium commonly used by patients with chronic obstructive pulmonary disease or COPD.
_Two additional quick-acting alternatives to albuterol, metaproterenol and pirbuterol.
_And two corticosteroids, inflammation-reducing drugs, called flunisolide and triamcinolone.